Skip to main content
. 2022 Mar 28;32(7):4555–4564. doi: 10.1007/s00330-022-08599-5

Table 3.

Patient characteristics per MRV-based thrombus age group

Acute
N = 27
Subacute
N = 17
Old
N = 12
Total
N = 56
Age, years—mean ± SD 51.7 ± 16.0 54.1 ± 17.5 44.1 ± 15.2 50.8 ± 16.4
Age, years—categories

- < 40 years

- 40 – 65 years

- > 65 years

6 (22.2%)

15 (55.6%)

6 (22.2%)

4 (23.5%)

6 (35.3%)

7 (41.2%)

4 (33.3%)

6 (50.0%)

2 (16.7%)

14 (25.0%)

27 (48.2%)

15 (26.8%)

sex, male 16 (59.3%) 8 (47.1%) 5 (41.7%) 29 (51.8%)
Affected side*

- Left

- Right

- Bothsided

18 (66.7%)

8 (29.6%)

1 (3.7%)

17 (100.0%)

0

0

3 (25.0%)

8 (66.7%)

1 (8.3%)

38 (67.9%)

16 (28.6%)

2 (3.6%)

BMI—mean ± SD 28.1 ± 5.9 28.2 ± 3.7 29.2 ± 8.3 28.4 ± 5.9
BMI, categories

- < 25.0

- 25.0 – 29.9

- ≥ 30.0

- Unknown

9 (33.3%)

10 (37.0%)

7 (25.9%)

1 (3.7%)

4 (23.5%)

8 (47.1%)

5 (29.4%)

0

4 (33.3%)

5 (41.7%)

3 (25.0%)

0

17 (30.4%)

23 (41.1%)

15 (26.8%)

1 (1.8%)

Duration of complaints at MRV imaging, days—mean ± SD 8.5 ± 4.5 9.8 ± 5.5 14.0 ± 4.2 10.1 ± 5.2
Duration between MRV and start thrombolysis, days—mean ± SD 0.96 ± 2.0 1.59 ± 2.7 1.08 ± 1.93 1.2 ± 2.2
Duration of complaints at start thrombolysis, days—mean ± SD§ 9.5 ± 5.1 11.4 ± 4.9 15.1 ± 4.0 11.3 ± 5.2
Duration of complaints at start thrombolysis, categories

- 0 – 7 days

- 7 – 14 days

- 14 – 21 days

- > 21 days

- Unknown

9 (33.3%)

12 (44.4%)

4 (14.8%)

1 (3.7%)

1 (3.7%)

2 (11.8%)

9 (52.9%)

6 (35.3%)

0

0

0

4 (33.3%)

7 (58.3%)

1 (8.3%)

0

11 (19.6%)

25 (44.6%)

17 (30.4%)

2 (3.6%)

1 (1.8%)

Successful thrombolysis§ 19 (70.4%) 11 (64.7%) 2 (16.7%) 32 (57.1%)
Total time of thrombolysis, h—mean ± SD 23.3 ± 7.4 47.9 ± 19.3 85.3 ± 16.3 44.1 ± 27.8
Complications, major bleeding 1 (3.7%) 2 (11.8%) 0 3 (5.4%)

Data are n (%) or mean (SD)

*p = 0.002, p = 0.000, p = 0.007, §p = 0.006, p = 0.026 ǁ